Organogenesis Holdings Inc.
USD2.33
+0.09 (+4.02%)
CEO
Gary S. Gillheeney
IPO Date
2017-01-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$2.23
Prev. Close
$2.24
Day Low
$2.21
Day High
$2.37
52W Low
$2.04
52W High
$7.08
Market Cap
$0.30B
Volume
0.81M
| 958 |
| $1.24 |
| 11 Mar 2026 | Leibowitz Arthur S | director | P-Purchase | Acquired | 5,000 | $2.68 |
| 11 Mar 2026 | Driscoll Michael Joseph | director | P-Purchase | Acquired | 10,000 | $2.67 |
| 3 Mar 2026 | Cavorsi Robert | Vice President, Strategy | F-InKind | Disposed | 700 | $3.21 |
| 3 Mar 2026 | Montecalvo Antonio S. | Vice President, Health Policy | A-Award | Acquired | 11,330 | $0.00 |
| 3 Mar 2026 | Montecalvo Antonio S. | Vice President, Health Policy | F-InKind | Disposed | 3,778 | $3.84 |
| 3 Mar 2026 | Gillheeney Gary S. | director, officer: President and CEO | A-Award | Acquired | 188,856 | $0.00 |
| 3 Mar 2026 | Gillheeney Gary S. | director, officer: President and CEO | F-InKind | Disposed | 91,311 | $3.84 |
| 3 Mar 2026 | Grow Brian | Chief Commercial Officer | A-Award | Acquired | 48,818 | $0.00 |